Estrella Immunopharma, Inc. ESLA
Set alert
0.64 USD -0.09 -12.27%
At close · Oct 30
0.66 +0.02 +3.24%
After hours · Oct 30, 4:00 PM ET
0.6335 Day range 0.7869
0.314 52-week range 3.05
- YTD
- -59.02%
- 1 year
- -74.93%
- Open
- 0.72
- Prev close
- 0.7287
- Mkt cap
- 27.81M
- Vol
- 165.73K
- Avg vol
- 1.78M
- EPS
- -0.25
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 0.6335
- High
- 0.7869
- Forward P/E
- 0.00
- Beta
- 0.24
- Short ratio
- 0.07
- Inst. own
- 0.55%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 0.97534
- 200-d avg
- 1.10
- 1y target
- 0.00
2Y chart
Signals (92)
| Name | Date | Ago |
|---|---|---|
| RSI: Overbought | Oct 27, 2026 | 5 days ago |
| RSI: Overbought | Oct 23, 2026 | 1 week ago |
| SMA: Bullish | Oct 22, 2026 | 1 week ago |
| MACD: Buy Signal | Oct 15, 2026 | 2 weeks ago |
| MACD: Sell Signal | Oct 12, 2026 | 2 weeks ago |
| MACD: Buy Signal | Oct 8, 2026 | 3 weeks ago |
| RSI: Oversold | Oct 5, 2026 | 3 weeks ago |
| RSI: Oversold | Sep 17, 2026 | 1 month ago |
| MACD: Sell Signal | Sep 3, 2026 | 1 month ago |
| MACD: Buy Signal | Aug 4, 2026 | 2 months ago |
| MACD: Sell Signal | Aug 3, 2026 | 3 months ago |
| MACD: Buy Signal | Jul 29, 2026 | 3 months ago |
| RSI: Oversold | Jul 15, 2026 | 3 months ago |
| MACD: Sell Signal | Jul 13, 2026 | 3 months ago |
| MACD: Buy Signal | Jun 26, 2026 | 4 months ago |
| MACD: Sell Signal | Jun 18, 2026 | 4 months ago |
| MACD: Buy Signal | Jun 4, 2026 | 5 months ago |
| SMA: Bearish | May 6, 2026 | 5 months ago |
| SMA: Bearish | May 6, 2026 | 5 months ago |
| MACD: Sell Signal | Apr 24, 2026 | 6 months ago |
| RSI: Overbought | Apr 17, 2026 | 6 months ago |
| RSI: Overbought | Apr 7, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 6 months ago |
| SMA: Bullish | Apr 6, 2026 | 6 months ago |
| MACD: Buy Signal | Apr 2, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 18, 2026 | 7 months ago |
| MACD: Buy Signal | Mar 11, 2026 | 7 months ago |
| SMA: Bullish | Mar 10, 2026 | 7 months ago |
| MACD: Sell Signal | Mar 2, 2026 | 8 months ago |
| SMA: Bearish | Feb 9, 2026 | 8 months ago |
| SMA: Bullish | Feb 6, 2026 | 8 months ago |
| SMA: Bullish | Feb 5, 2026 | 8 months ago |
| MACD: Buy Signal | Jan 26, 2026 | 9 months ago |
| RSI: Oversold | Jan 13, 2026 | 9 months ago |
| SMA: Bearish | Jan 9, 2026 | 9 months ago |
| MACD: Sell Signal | Dec 12, 2025 | 10 months ago |
| SMA: Bearish | Dec 11, 2025 | 10 months ago |
| MACD: Buy Signal | Dec 8, 2025 | 10 months ago |
| SMA: Bullish | Dec 4, 2025 | 11 months ago |
| SMA: Bearish | Dec 1, 2025 | 11 months ago |
| SMA: Bullish | Nov 24, 2025 | 11 months ago |
| SMA: Bearish | Nov 19, 2025 | 11 months ago |
| MACD: Sell Signal | Nov 11, 2025 | 11 months ago |
| RSI: Overbought | Oct 17, 2025 | 1 year ago |
| RSI: Overbought | Oct 14, 2025 | 1 year ago |
| MACD: Buy Signal | Oct 13, 2025 | 1 year ago |
| MACD: Sell Signal | Oct 9, 2025 | 1 year ago |
| RSI: Overbought | Oct 6, 2025 | 1 year ago |
| RSI: Overbought | Oct 1, 2025 | 1 year ago |
| RSI: Overbought | Sep 17, 2025 | 1 year ago |
| SMA: Bullish | Sep 9, 2025 | 1 year ago |
| SMA: Bearish | Sep 8, 2025 | 1 year ago |
| RSI: Overbought | Sep 3, 2025 | 1 year ago |
| SMA: Bullish | Aug 29, 2025 | 1 year ago |
| SMA: Bullish | Aug 22, 2025 | 1 year ago |
| SMA: Bearish | Aug 21, 2025 | 1 year ago |
| SMA: Bullish | Aug 15, 2025 | 1 year ago |
| MACD: Buy Signal | Aug 12, 2025 | 1 year ago |
| MACD: Sell Signal | Aug 4, 2025 | 1 year ago |
| SMA: Bearish | Jul 30, 2025 | 1 year ago |
| SMA: Bullish | Jul 29, 2025 | 1 year ago |
| SMA: Bearish | Jul 25, 2025 | 1 year ago |
| SMA: Bullish | Jul 24, 2025 | 1 year ago |
| MACD: Buy Signal | Jul 22, 2025 | 1 year ago |
| SMA: Bearish | Jun 23, 2025 | 1 year ago |
| SMA: Bullish | Jun 20, 2025 | 1 year ago |
| SMA: Bearish | Jun 13, 2025 | 1 year ago |
| MACD: Sell Signal | Jun 13, 2025 | 1 year ago |
| MACD: Buy Signal | Jun 6, 2025 | 1 year ago |
| SMA: Bullish | Jun 4, 2025 | 1 year ago |
| SMA: Bearish | Jun 2, 2025 | 1 year ago |
| SMA: Bullish | May 19, 2025 | 1 year ago |
| SMA: Bearish | May 15, 2025 | 1 year ago |
| MACD: Sell Signal | May 13, 2025 | 1 year ago |
| SMA: Bullish | Apr 25, 2025 | 1 year ago |
| SMA: Bearish | Apr 24, 2025 | 1 year ago |
| SMA: Bullish | Apr 23, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 21, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 17, 2025 | 1 year ago |
| MACD: Buy Signal | Apr 9, 2025 | 1 year ago |
| MACD: Sell Signal | Apr 1, 2025 | 1 year ago |
| MACD: Buy Signal | Mar 21, 2025 | 1 year ago |
| MACD: Sell Signal | Feb 26, 2025 | 1 year ago |
| SMA: Bearish | Feb 25, 2025 | 1 year ago |
| SMA: Bullish | Feb 14, 2025 | 1 year ago |
| MACD: Buy Signal | Feb 13, 2025 | 1 year ago |
| SMA: Bearish | Jan 30, 2025 | 1 year ago |
| SMA: Bullish | Jan 29, 2025 | 1 year ago |
| SMA: Bearish | Jan 28, 2025 | 1 year ago |
| RSI: Overbought | Dec 9, 2024 | 1 year ago |
| RSI: Overbought | Dec 5, 2024 | 1 year ago |
| RSI: Overbought | Nov 29, 2024 | 1 year ago |
Key statistics
- Market cap
- 40.88M
- Enterprise value
- 28.05M
- Trailing P/E
- 0.00
- Forward P/E
- 0.00
- PEG ratio
- 0.00
- Price / sales
- 0.00
- Price / book
- 9.58
- EPS (TTM)
- -0.24
- Beta
- 0.24
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- 0.00%
- Revenue (TTM)
- 0
- Revenue growth
- 0.00%
- Free cash flow
- -12.95M
- Total cash
- 4.17M
- Total debt
- 4.00K
- Return on equity
- 0.00%
- Shares outstanding
- 36.18M
- Short % of float
- 0.06%
- 50-day average
- 0.97534
- 200-day average
- 1.10
Analyst view
Consensus: none
Price target (mean) 0.00
Next earnings
Consensus EPS estimate 0.00.
Financials — quick view
ESLA Revenue — quarterly 0
ESLA Net income — quarterly -2.31M
ESLA EPS — quarterly -0.05
About Estrella Immunopharma, Inc.
Estrella Immunopharma, Inc., a clinical-stage biopharmaceutical company, develops T-cell therapies for blood cancers and solid tumors in the United States. The company's lead product candidates include EB103, which is in clinical trial, for the treatment of diffuse large B-cell lymphoma; EB104, which is in pre-clinical trial, to treat diffuse large B-cell lymphoma and acute lymphocytic leukemia; and EB201, which is in pre-clinical trial, for the treatment of systemic lupus erythematosus. It has a collaborative agreement with Imugene Limited for the development of solid tumor treatments using Imugene's product candidate CF33-CD19t in conjunction with EB103. Estrella Immunopharma, Inc. was founded in 2006 and is headquartered in EmeryVille, California.
- Sector
- Healthcare
- Industry
- Biotechnology
- Country
- United States
- Website
- estrellabio.com
News
- Estrella Immunopharma Appoints Cynthia Pussinen CEO, Chairperson, Effective Oct. 25, Succeeding Cheng Liu
- Estrella Immunopharma Appoints Cynthia Pussinen as Chief Executive Officer and Chairperson of the Board of Directors
- 12 Health Care Stocks Moving In Friday's Intraday Session
- 12 Health Care Stocks Moving In Thursday's After-Market Session
- 12 Health Care Stocks Moving In Thursday's Intraday Session
- Estrella Immunopharma (ESLA) Stock Soars 18%: What’s Driving the Surge
- 12 Health Care Stocks Moving In Wednesday's Intraday Session
- 12 Health Care Stocks Moving In Monday's Intraday Session
- 12 Health Care Stocks Moving In Monday's Pre-Market Session
- Estrella Immunopharma Treats First Patient with Two EB103 Infusions in STARLIGHT-1 Dose-Expansion Phase
Your note
Sign in to keep a note on ESLA — it syncs with the Stock Master app.
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Geode Capital Management, LLC | 0.21% | 76,556 | 86.51K | Sep 29, 2024 |
| ATW Spac Management LLC | 0.11% | 40,000 | 45.20K | Sep 29, 2024 |
| Blackrock Inc. | 0.07% | 24,963 | 28.21K | Sep 29, 2024 |
| Vanguard Group Inc | 0.06% | 21,684 | 24.50K | Sep 29, 2024 |
| Citadel Advisors Llc | 0.04% | 14,531 | 16.42K | Sep 29, 2024 |
| Maso Capital Partners Ltd. | 0.03% | 10,000 | 11.30K | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Fidelity Extended Market Index Fund | 0.16% | 56,779 | 64.16K | Oct 30, 2024 |
| iShares Micro Cap ETF | 0.06% | 22,435 | 25.35K | Oct 30, 2024 |
| Vanguard Total Stock Market Index Fund | 0.05% | 17,968 | 20.30K | Sep 29, 2024 |
| Fidelity Total Market Index Fund | 0.05% | 16,862 | 19.05K | Oct 30, 2024 |
| Fidelity Series Total Market Index Fund | 0.04% | 13,413 | 15.16K | Oct 30, 2024 |
| EQ Advisors Trust-1290 VT Micro Cap Port | 0.01% | 2,373 | 2.68K | Sep 29, 2024 |